MedTrace Logo

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

NCT02654509 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2020-03-17

No results posted yet for this study

Summary

This study is being conducted to collect safety and immunogenicity data for the Eastern Equine Encephalitis (EEE) vaccine.

Conditions

  • Eastern Equine Encephalitis

Interventions

BIOLOGICAL

Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104

Eastern Equine Encephalitis Vaccine, Inactivated, Dried

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    lead FED

Principal Investigators

  • Robert Rivard, MD · US Army Medical Research Institute of Infectious Diseases

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-03
Primary Completion
2016-02-16
Completion
2018-03-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654509 on ClinicalTrials.gov